UNSPSC 85521226: Supplement right internal jugular vein with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right internal jugular vein with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UM3JZ

UNSPSC 85521226, Supplement right internal jugular vein with synthetic substitute, percutaneous approach, is a Commodity code that does not align with recent state and local procurement activity in the source material. The code's nominal scope describes a specific surgical procedure — endovascular supplementation of the internal jugular vein using a synthetic material — yet the recent solicitations posted under this code span independent medical evaluation services, surgical benefit carve-outs for health plans, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these activities involve the procedure named in the code. The mismatch suggests either miscoding at the issuing body level or a taxonomy misapplication in the underlying data source.

The recent opportunities show no coherent procurement pattern under this Commodity code. Issuing bodies include the City of Phoenix Retirement Office (medical record review and independent disability examinations), the City of Long Beach (Center of Excellence surgical networks), the Washington State Department of Transportation (occupational health surveillance), Harris County Juvenile Probation Department (emergency and specialty hospital services for youth), Collier County Board of County Commissioners (pharmacy benefits administration), and the County of Santa Clara Health System (temporary ancillary clinical staffing). Geographic spread spans Arizona, California, Washington, Texas, and Florida. Because the recent opportunities in the source do not address the specific surgical procedure or any comparable endovascular intervention, the code shows little relevant activity for vendors focused on internal jugular vein repair, vascular access devices, or related implantable technology.